Art

J-GLOBAL ID：201202271788918691   Reference number：12A0138997

Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs

シスプラチンのミセル化(NC-6004)によるモルモットにおける聴器毒性の低下

Author (7)： BABA Miyuki ,  MATSUMOTO Yu ,  KASHIO Akinori ,  CABRAL Horacio ,  NISHIYAMA Nobuhiro ,  KATAOKA Kazunori ,  YAMASOBA Tatsuya
Material： Journal of Controlled Release  (J Control Release)
Volume： 157  Issue： 1  Page： 112-117  Publication year： Jan. 10, 2012 
JST Material Number： C0308D  ISSN： 0168-3659  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *drug poisoning ,...
Semi thesaurus term： *cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0138997&from=J-GLOBAL&jstjournalNo=C0308D") }}

JST classification (4)： Basic research of antitumor(=antineoplastic)drugs  (GW16010A) ,  Toxicity of inorganic compounds in general  (GZ02021E) ,  Basic otorhinolaryngology  (GQ01020F) ,  Poisoning in general  (GD06010Q)

Reference (38)：

• P.A. Vasey, S.B. Kaye, R. Morrison, C. Twelves, P. Wilson, R. Duncan, A.H. Thomson, L.S. Murray, T.E. Hilditch, T. Murray, S. Burtles, D. Fraier, E. Frigerio, J. Cassidy, Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl) methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee, Clin. Cancer Res. 5 (1999) 83-94.
• T. Lian, R.J. Ho, Trends and developments in liposome drug delivery systems, J. Pharm. Sci. 90 (2001) 667-680.
• M.E. Davis, Z.G. Chen, D.M. Shin, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat. Rev. Drug Discov. 7 (2008) 771-782.
• M. Orditura, F. Quaglia, F. Morgillo, E. Martinelli, E. Lieto, G. De Rosa, D. Comunale, M.R. Diadema, F. Ciardiello, G. Catalano, F. De Vita, Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review), Oncol. Rep. 12 (2004) 549-556.
• Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res. 46 (1986) 6387-6392.

Terms in the title (5)： シスプラチン ,  ミセル化 ,  NC ,  モルモット ,  聴器毒性